The Psilocybin Timeline: where we are, where we're going, and how we get there. With Timmy Davis.

The Psilocybin Access Rights (PAR) campaign has developed below and between the grassroots, sprawling across the UK, fruiting and spreading its spores at parties, conferences and music festivals in an attempt to reach the hearts and minds of those politicians who could implement changes to facilitate research into psychedelic medicines and prescription access for those suffering mental health difficulties. This talk will introduce the campaign and how it has been inspired by the mushrooms themselves. You can expect to learn about the history of efforts to change the law in the UK and abroad, what the future of psychedelic-assisted therapy in the UK might look like and how you can get involved in making it happen.

Please note: This event is included in Festival Passes

Timmy Davis works on the clinical and political interpretation of psychedelic experience. He is director of Psychedelic Policy and Regulation at the Centre for Evidence Based Drug Policy (CEBDP), through whom he co-founded and runs the Feilding Commission. He is the founder of The Psychedelic Experience Clinic and also policy director and co-founder of the Psilocybin Access Rights (PAR) campaign and a trainee at the Site for Contemporary Psychoanalysis. He graduated from Birkbeck, University of London with an MA in Psychoanalytic Studies and with a BA Hons in Philosophy and Religious Studies from the University of Kent, where he was president of the psychedelic society for three years. He has provided psychological support on the psilocybin for treatment-resistant depression trials at King's College London and led teams of volunteers in welfare and harm reduction spaces such as Kosmicare at Boom Festival in Portugal and at festivals across the UK.

Timmy co-authored a chapter entitled The Feminine Enshadowed: the Role of Psychedelics in Deconstructing the Gender Binary in the book Psychedelic Mysteries of the Feminine (2019), The Medicinal Use of Psilocybin: Reducing Restrictions on Research and Treatment (2020) and Kava: Honoured in the Pacific, Banned in the UK (2026). He also authored New, Strange, Odd and Weird Perceptions - A Lacanian Approach to Psychedelic Experience (Lacunae, 2020), THOU ART NOT THAT - Towards a Psychoanalytic Understanding of the Bad Trip (Breaking Convention, 2022) and "Undreamt of possibilities" a genealogy of 'psychedelic' therapeutics - or the drugs work, but how? (Breaking Convention, 2025).

He is currently writing a book titled The Interpretation of Psychedelic Experience, exploring how psychedelics work by destabilising established interpretative frameworks, and the clinical and political consequences that follow. www.timmydavis.co.uk